Hong Kong Glaucoma Treatment Market Research Report 2019

Table of Contents

1 Industry Overview 1

• 1.1 Glaucoma Treatment Market Overview 1
  • 1.1.1 Glaucoma Treatment Product Scope 1
  • 1.1.2 Market Status and Outlook 2
• 1.2 Hong Kong Glaucoma Treatment Market by Product 2
  • 1.2.1 Hong Kong Glaucoma Treatment Revenue and Growth Comparison by Product (2013-2025) 2
  • 1.2.2 Hong Kong Glaucoma Treatment Revenue Market Share by Product in 2018 3
  • 1.2.3 Prostaglandin Analogs (PGAs) 4
  • 1.2.4 Alpha Agonist 5
  • 1.2.5 Beta Blockers 6
• 1.3 Hong Kong Glaucoma Treatment Market by End Users/Application 7
  • 1.3.1 Pharmacy 8
  • 1.3.2 Clinics 8
  • 1.3.3 Others 9
• 1.4 Glaucoma Treatment Development History and Outlook 9
  • 1.4.1 Glaucoma Treatment Development History and Status 9
  • 1.4.2 Glaucoma Treatment Development Outlook 13

2 Hong Kong Glaucoma Treatment Competition Analysis by Players 15

• 2.1 Hong Kong Glaucoma Treatment Market Size (Value) by Players (2017-2018) 15
• 2.2 Competitive Status and Trend 18
  • 2.2.1 Market Concentration Rate 18
  • 2.2.2 Product/Service Differences 18
  • 2.2.3 New Entrants 19
  • 2.2.4 The Technology Trends in Future 21

3 Analysis of Glaucoma Treatment Industry Key Manufacturers 24

• 3.1 Novartis 24
  • 3.1.1 Company Profile 24
  • 3.1.2 Product Information 26
  • 3.1.3 Revenue and Gross Margin 26
• 3.2 Allergan 27
  • 3.2.1 Company Profile 27
  • 3.2.2 Product Information 28
  • 3.2.3 Revenue and Gross Margin 28
• 3.3 Pfizer 29
  • 3.3.1 Company Profile 29
  • 3.3.2 Product Information 31
  • 3.3.3 Revenue and Gross Margin 31
• 3.4 Akorn 32
  • 3.4.1 Company Profile 32
  • 3.4.2 Product Information 33
  • 3.4.3 Revenue and Gross Margin 33
• 3.5 Teva 34
  • 3.5.1 Company Profile 34
  • 3.5.2 Product Information 35
  • 3.5.3 Revenue and Gross Margin 35
• 3.6 Bausch & Lomb 36
  • 3.6.1 Company Profile 36
  • 3.6.2 Product Information 37
  • 3.6.3 Revenue and Gross Margin 37
• 3.7 Otsuka Pharmaceutical 38
  • 3.7.1 Company Profile 38
  • 3.7.2 Product Information 39
  • 3.7.3 Revenue and Gross Margin 39
• 3.8 Santen 40
  • 3.8.1 Company Profile 40
  • 3.8.2 Product Information 41
  • 3.8.3 Revenue and Gross Margin 41
• 3.9 Lunan Pharma 42
  • 3.9.1 Company Profile 42
  • 3.9.2 Product Information 43
  • 3.9.3 Revenue and Gross Margin 43
• 3.10 Zizhu Pharma 44
  • 3.10.1 Company Profile 44
  • 3.10.2 Product Information 45
  • 3.10.3 Revenue and Gross Margin 45

4 Hong Kong Glaucoma Treatment Market Size by Product (2013-2018) 46

• 4.1 Hong Kong Glaucoma Treatment Market Size by Product (2013-2018) 46
• 4.2 Prostaglandin Analogs (PGAs) Development in Hong Kong 48
• 4.3 Alpha Agonist Development in Hong Kong 48
• 4.4 Beta Blockers Development in Hong Kong 49
• 4.5 Others Product Development in Hong Kong 49

5 Hong Kong Glaucoma Treatment Market Size by Application/End Users (2013-2018) 50

• 5.1 Hong Kong Glaucoma Treatment Market Size by Application (2013-2018) 50
• 5.2 Pharmacy Development in Hong Kong 52
• 5.3 Clinics Development in Hong Kong 52
• 5.4 Others Development in Hong Kong 53

6 Glaucoma Treatment Market Dynamics 54

• 6.1 Glaucoma Treatment Market Opportunities 54
• 6.2 Glaucoma Treatment Challenge and Risk 55
  • 6.2.1 Competition from Opponents 55
  • 6.2.2 Risk Factors 55
• 6.3 Glaucoma Treatment Market Constraints and Threat 56

7 Market Effect Factors Analysis 58

• 7.1 Technology Progress/Risk 58
• 7.2 Consumer Needs Trend/Customer Preference 59
• 7.3 Economic/Political Environmental Change 60

8 Hong Kong Glaucoma Treatment Market Forecast by Type and Application (2019-2025) 70

• 8.1 Hong Kong Glaucoma Treatment Market Size 2019-2025 70
• 8.2 Hong Kong Glaucoma Treatment Market Size (Value) by Type (2019-2025) 70
• 8.3 Hong Kong Glaucoma Treatment Market Size by Application (2019-2025) 72

9 Research Finding /Conclusion 75

10 Methodology and Data Source 76

• 10.1 Methodology/Research Approach 76
  • 10.1.1 Research Programs/Design 76
  • 10.1.2 Market Size Estimation 78
  • 10.1.3 Market Breakdown and Data Triangulation 80
• 10.2 Data Source 81
  • 10.2.1 Secondary Sources 81
  • 10.2.2 Primary Sources 82
• 10.3 Disclaimer 83
• 10.4 Author List 85